Balchem corporation completes acquisition of kappa bioscience as

New hampton, n.y., june 21, 2022 (globe newswire) -- balchem corporation (nasdaq:bcpc), a global specialty ingredients company focused on nutrition and health, today announced that it completed its acquisition of kappa bioscience as, a leading science-based manufacturer of specialty vitamin k2 for the human nutrition industry, headquartered in oslo, norway. the signing of a definitive agreement to acquire kappa bioscience as was previously announced on june 14, 2022.
BCPC Ratings Summary
BCPC Quant Ranking